A Multi-Centric, Single-Blinded, Randomized, Parallel-Group Study to Evaluate the Effectiveness of Nasoalveolar Moulding Treatment in Non-Syndromic Patients with Complete Unilateral Cleft Lip, Alveolus and Palate (NAMUC Study): a Study Protocol for a Randomized Controlled Trial.
Trials(2024)
摘要
Cleft lip and palate (CLP) are among the most common congenital anomaly that affects up to 33,000 newborns in India every year. Nasoalveolar moulding (NAM) is a non-surgical treatment performed between 0 and 6 months of age to reduce the cleft and improve nasal aesthetics prior to lip surgery. The NAM treatment has been a controversial treatment option with 51 https://ctri.nic.in/Clinicaltrials/advsearch.php —use the search boxes by entering the following details: Interventional trial > November 2022 > NAMUC).
更多查看译文
关键词
Randomized controlled trials,Cleft lip and palate,Nasoalveolar moulding,NAM treatment,CLP,PSIO,Presurgical infant orthopaedics
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要